Two new GSK oral oncology treatments approved by FDA
29 May 2013 | By GlaxoSmithKline
BRAF-inhibitor Tafinlar® (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib) tablets approved by FDA...
List view / Grid view
29 May 2013 | By GlaxoSmithKline
BRAF-inhibitor Tafinlar® (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib) tablets approved by FDA...
29 May 2013 | By GlaxoSmithKline
"We are delighted with the positive results..."
28 May 2013 | By Gilead Sciences
Gilead Sciences announced that the European Commission has granted marketing authorization for Stribild®...
28 May 2013 | By Boehringer Ingelheim
Findings from a pan-European online survey...
28 May 2013 | By AstraZeneca
AstraZeneca announced that it has entered into a definitive agreement to acquire Omthera Pharmaceuticals...
24 May 2013 | By Boehringer Ingelheim
"The aim and design of the game is simple..."
23 May 2013 | By Biogen Idec
Biogen Idec announced that Spyros Artavanis-Tsakonas, Ph.D., has been named the company’s Chief Scientific Officer...
23 May 2013 | By GlaxoSmithKline
Funding will support development of drugs to fight antibiotic resistance and bioterrorism...
23 May 2013 | By Sanofi
Sanofi is pleased to announce the appointment of David Loew, effective July 1st , 2013.
23 May 2013 | By Merck
Merck provides update on Phase III clinical program for preladenant, the company’s investigational parkinson’s disease medicine...
22 May 2013 | By Boehringer Ingelheim
AdhereTech receives $50,000 grand prize in global diabetes innovation challenge funded by Boehringer Ingelheim...
22 May 2013 | By Roche
System improves efficiency and speed of blood sample testing in medical labs...
21 May 2013 | By GlobalData
Italian pharmaceutical market value will continue to fall in the foreseeable future...
21 May 2013 | By Biogen Idec
EMA submission planned in the coming weeks...
21 May 2013 | By Gilead Sciences
Gilead Sciences announced that the company’s MAA for sofosbuvir...